Countering clinical inertia in lipid management: Expert workshop summary - 12/12/18
![](/templates/common/images/mail.png)
Plan
Jeffrey S. Berger, MD, MS served as guest editor for this article. |
|
Potential Conflicts of Interest Lisa Egbuonu-Davis is a Sanofi employee and stock owner. Anjali Trasy is a Sanofi employee and stock owner. Hayden Bosworth is a Duke and VA employee, received consulting funding from Sanofi and research funds from Sanofi, Otsuka, Improved Patient Outcomes, Cover My Meds, Blue Cross/Blue Shield of North Carolina. |
|
Disclaimers: The authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the manuscript, and its final contents. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, or Duke University. |
|
Disclosure: The expert panel workshop was solely funded by Sanofi. |
Vol 206
P. 24-29 - décembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?